Abbott Laboratoriesvs.Hologic
ABT vs HOLX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Abbott Laboratories is about 9.9× larger than Hologic by market cap; year to date, Hologic leads (+2.0% vs −21.2%).
Side by side
| ABT | HOLX | |
|---|---|---|
| Market cap | $168B | $17B |
| Price | $98.49 | — |
| Today | −0.2% | — |
| Return YTD | −21.2% | +2.0% |
| Return 1Y | −25.8% | −3.5% |
| P/E | 31.0 | 31.2 |
| P/S | 3.6 | 4.1 |
| P/B | 3.3 | 3.2 |
Data as of 2026-10-08 · updates daily after U.S. close
The two companies
Abbott LaboratoriesABT
In vitro diagnostics, medical devices that include the Libre glucose sensors, nutrition products and generic medicines: Abbott runs all four.
Full ABT profile →HologicHOLX
Women's health defines the range here, from molecular diagnostic tests to mammography systems and surgical products.
Full HOLX profile →More ABT & HOLX comparisons
Other head-to-heads in the Diagnostics segment.
See where ABT and HOLX sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →